Diltiazem Hydrochloride description, usages, side effects, indications, overdosage, supplying and lots more!

Diltiazem Hydrochloride

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

DESCRIPTION


DESCRIPTION






CLINICAL PHARMACOLOGY



Mechanisms of Action

Hypertension


Angina




Hemodynamic and Electrophysiologic Effects








PHARMACODYNAMICS





PHARMACOKINETICS AND METABOLISM









INDICATIONS & USAGE




CONTRAINDICATIONS



WARNINGS

Cardiac Conduction


Congestive Heart Failure


Hypotension


Acute Hepatic Injury
PRECAUTIONS

PRECAUTIONS

General

ADVERSE REACTIONS


INFORMATION FOR PATIENTS



DRUG INTERACTIONS

WARNINGSWARNINGS

Beta-Blockers
WARNINGS

Cimetidine


Clonidine


Digitalis
WARNINGS

Anesthetics


Statins




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY



PREGNANCY

Teratogenic Effects

Pregnancy Category C



NURSING MOTHERS



PEDIATRIC USE



ADVERSE REACTIONS



Hypertension



**
Angina



**
Infrequent Adverse Events


Hypertension












Angina












OVERDOSAGE


Bradycardia:
High-Degree AV Block:
Cardiac Failure:
Hypotension:




DOSAGE & ADMINISTRATION

Hypertension




Angina


Concomitant Use with Other Cardiovascular Agents

Sublingual Nitroglycerin


Prophylactic Nitrate Therapy


Beta-Blockers
WARNINGSPRECAUTIONS

Antihypertensives


HOW SUPPLIED


















STORAGE AND HANDLING




PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION

Diltiazem Hydrochloride

Diltiazem Hydrochloride CAPSULE, EXTENDED RELEASE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-815(NDC:0378-5280)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
DILTIAZEM HYDROCHLORIDE DILTIAZEM 180 mg

Inactive Ingredients

Ingredient Name Strength
AMMONIA
SILICON DIOXIDE
DIBUTYL SEBACATE
D&C YELLOW NO. 10
ETHYLCELLULOSES
FD&C RED NO. 40
FD&C BLUE NO. 1
FD&C BLUE NO. 2
GELATIN
HYPROMELLOSES
MAGNESIUM STEARATE
maltodextrin
cellulose, microcrystalline
OLEIC ACID
polyethylene glycol
propylene glycol
SODIUM LAURYL SULFATE
FERROSOFERRIC OXIDE
titanium dioxide
D&C RED NO. 28
SHELLAC

Product Characteristics

Color Size Imprint Code Shape
pink 15 mm MYLAN;5280 CAPSULE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-815-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075124 2011-11-15


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.